These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25877779)

  • 1. Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
    Kloprogge F; McGready R; Phyo AP; Rijken MJ; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Day NP; White NJ; Nosten F; Tarning J
    Br J Clin Pharmacol; 2015 Oct; 80(4):642-53. PubMed ID: 25877779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
    Morris CA; Onyamboko MA; Capparelli E; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright L; Tshefu AK; Meshnick S; Fleckenstein L
    Malar J; 2011 May; 10():114. PubMed ID: 21548983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
    McGready R; Phyo AP; Rijken MJ; Tarning J; Lindegardh N; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Singhasivanon P; White NJ; Nosten F
    Br J Clin Pharmacol; 2012 Mar; 73(3):467-77. PubMed ID: 21950338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
    Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
    Valea I; Tinto H; Traore-Coulibaly M; Toe LC; Lindegardh N; Tarning J; Van Geertruyden JP; D'Alessandro U; Davies GR; Ward SA
    J Antimicrob Chemother; 2014 Sep; 69(9):2499-507. PubMed ID: 24891429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.
    Onyamboko MA; Meshnick SR; Fleckenstein L; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright LL; Tshefu AK; Capparelli EV
    Malar J; 2011 Feb; 10():49. PubMed ID: 21352601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
    Hoglund RM; Ruengweerayut R; Na-Bangchang K
    Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
    Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
    Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
    Saunders D; Khemawoot P; Vanachayangkul P; Siripokasupkul R; Bethell D; Tyner S; Se Y; Rutvisuttinunt W; Sriwichai S; Chanthap L; Lin J; Timmermans A; Socheat D; Ringwald P; Noedl H; Smith B; Fukuda M; Teja-Isavadharm P
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5484-93. PubMed ID: 22869581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
    McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
    Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
    Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.
    Suputtamongkol Y; Newton PN; Angus B; Teja-Isavadharm P; Keeratithakul D; Rasameesoraj M; Pukrittayakamee S; White NJ
    Br J Clin Pharmacol; 2001 Dec; 52(6):655-61. PubMed ID: 11736876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
    Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
    Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
    Newton P; Suputtamongkol Y; Teja-Isavadharm P; Pukrittayakamee S; Navaratnam V; Bates I; White N
    Antimicrob Agents Chemother; 2000 Apr; 44(4):972-7. PubMed ID: 10722499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
    Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
    Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin.
    Hall AJ; Chappell MJ; Aston JA; Ward SA
    Comput Methods Programs Biomed; 2013 Oct; 112(1):1-15. PubMed ID: 23871681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated
    Birgersson S; Valea I; Tinto H; Traore-Coulibaly M; Toe LC; Hoglund RM; Van Geertruyden JP; Ward SA; D'Alessandro U; Abelö A; Tarning J
    Wellcome Open Res; 2019; 4():45. PubMed ID: 32025570
    [No Abstract]   [Full Text] [Related]  

  • 20. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.
    Batty KT; Thu LT; Davis TM; Ilett KF; Mai TX; Hung NC; Tien NP; Powell SM; Thien HV; Binh TQ; Kim NV
    Br J Clin Pharmacol; 1998 Feb; 45(2):123-9. PubMed ID: 9491824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.